Pharma, tech giants complained of Canada’s drug pricing system, digital service tax to U.S. trade rep
The board that oversees medicine prices in Canada and levies on big social media and online service platforms appear in submissions to the U.S. Trade Representatives review of 'unfair' foreign trading practices.
In the weeks leading up to United States President Donald Trump’s imposition of so-called “reciprocal” tariffs on much of the world, American tech and pharmaceutical giants lobbied their government to take action against Canada’s digital services tax and drug-pricing...
Get Innovation & Industry Newsletter
From investment to regulation, the policies, decisions and people working on industry and innovation. Tuesday.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
